Pre-book for 2021-2022
Now Open
Pre-book reservations can now be placed for the 2021-2022 flu season.
Now available: flu360™
Flu Vaccination Reminder
Program
Use this resource to communicate with and encourage your patients to schedule an appointment for their flu vaccination.
Talk to your Seqirus sales representative to sign up.
COVID-19 UPDATE
Click here to learn more about how Seqirus is responding to the COVID-19 pandemic.
Seqirus offers one of the most comprehensive portfolios of influenza products all year round.
The first FDA-approved seasonal influenza vaccine made with MF59®, an immune-enhancing adjuvant proven to help provide a strong immune response to influenza for adults 65 and older.1,2
The first and only cell-based quadrivalent influenza vaccine in the US that offers prevention against 4 influenza strains – virus subtypes A and type B contained within the vaccine -for people 4 years and older.3,4
A quadrivalent influenza vaccine for people 6 months and older manufactured through the traditional egg-based process.5
References
- FLUAD QUADRIVALENT [package insert]. Holly Springs, NC: Seqirus Inc; 2020.
- O’Hagan DT, Ott GS, Nest GV, Rappuoli R, Giudice GD. The history of MF59® adjuvant: a phoenix that arose from the ashes. Expert Rev Vaccines. 2013; 12(1):13-30.
- Banzhoff A, Pellegrini M, Del Giudice G, Fragapane E, Groth N, Podda A. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis. Influenza Other Respir Viruses. 2008; 2(6):243-249.
- FLUAD [package insert]. Holly Springs, NC: Seqirus Inc; 2019.
- FLUCELVAX QUADRIVALENT [package insert]. Holly Springs, NC: Seqirus Inc; 2019.
- AFLURIA QUADRIVALENT [package insert]. Summit, NJ: Seqirus USA Inc; 2019.
LEARN.
ORDER.
MANAGE.
By creating an account with us, you can see specific product
pricing, make a purchase, and manage your shipments easily.